Does TREPROSTINIL Cause Incorrect product administration duration? 27 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 27 reports of Incorrect product administration duration have been filed in association with TREPROSTINIL (TYVASO). This represents 0.0% of all adverse event reports for TREPROSTINIL.
27
Reports of Incorrect product administration duration with TREPROSTINIL
0.0%
of all TREPROSTINIL reports
0
Deaths
8
Hospitalizations
How Dangerous Is Incorrect product administration duration From TREPROSTINIL?
Of the 27 reports, 8 (29.6%) required hospitalization, and 1 (3.7%) were considered life-threatening.
Is Incorrect product administration duration Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TREPROSTINIL. However, 27 reports have been filed with the FAERS database.
What Other Side Effects Does TREPROSTINIL Cause?
Dyspnoea (16,348)
Headache (14,051)
Diarrhoea (11,335)
Nausea (10,320)
Cough (8,945)
Fatigue (7,440)
Dizziness (7,405)
Infusion site pain (5,169)
Vomiting (5,097)
Death (4,764)
What Other Drugs Cause Incorrect product administration duration?
ETONOGESTREL (3,974)
POLYETHYLENE GLYCOL 3350 (2,129)
NIRMATRELVIR\RITONAVIR (744)
DOCOSANOL (634)
LANSOPRAZOLE (564)
LOPERAMIDE (543)
NAPROXEN (499)
INSULIN LISPRO (479)
DICLOFENAC (362)
OMEPRAZOLE (302)
Which TREPROSTINIL Alternatives Have Lower Incorrect product administration duration Risk?
TREPROSTINIL vs TREPROSTINIL DIOLAMINE
TREPROSTINIL vs TRETINOIN
TREPROSTINIL vs TRIAMCINOLONE
TREPROSTINIL vs TRIAMCINOLONE ACETONIDE
TREPROSTINIL vs TRIAMCINOLONE HEXACETONIDE